TELAHealthcareNano-Cap

TELA Bio, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for TELA Bio, Inc. (TELA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are TELA insiders buying or selling?

TELA Bio, Inc. insiders reported 99 open-market buys ($51.7M) and 3 sells ($4.2M) across 102 Form 4 filings — a net buying position of $47.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Nov 17, 2025)

Total Form 4 filings
102
SEC EDGAR
Insider filers
12
Insider buys (99)
$51.7M
Insider sells (3)
$4.2M

Insider sentiment

Net buying

Net insider flow of $47.5M in net buying.

Recent TELA insider transactions

DateInsiderRoleTypeSharesPriceValue
Nov 17, 2025EW HEALTHCARE PARTNERS FUND 2, L.P.Other, 10% OwnerPurchase3.6M$1.11$4.0M
Oct 24, 2024Roberto CucaCOO and CFOPurchase64.4K$2.25$145.0K
Oct 24, 2024Paul TalmoChief Technology OfficerPurchase22.2K$2.25$50.0K
Oct 24, 2024Antony KoblishChief Executive OfficerPurchase88.9K$2.25$200.0K
Oct 24, 2024Gregory A. FirestoneChief Commercial OfficerPurchase6.7K$2.25$15.0K
Jul 2, 2024ORBIMED ADVISORS LLC10% OwnerSale428.3K$4.72$2.0M
Feb 16, 2024EW HEALTHCARE PARTNERS FUND 2, L.P.Other, 10% OwnerPurchase326.1K$9.32$3.0M
Dec 7, 2023Gregory A. FirestoneChief Business OfficerPurchase2.6K$5.65$14.7K
Nov 15, 2023Roberto CucaCOO and CFOPurchase10.0K$4.49$44.9K
Nov 15, 2023Antony KoblishChief Executive OfficerPurchase11.0K$4.54$50.0K
Apr 21, 2023ORBIMED ADVISORS LLC10% OwnerSale192.0K$9.34$1.8M
Nov 4, 2022Opaleye Management Inc.10% OwnerPurchase20.3K$7.81$158.3K
Oct 11, 2022Opaleye Management Inc.10% OwnerPurchase16.0K$8.00$128.0K
Sep 26, 2022Opaleye Management Inc.10% OwnerPurchase6.8K$7.99$54.4K
Sep 19, 2022Opaleye Management Inc.10% OwnerPurchase18.0K$8.09$145.6K
Sep 16, 2022Opaleye Management Inc.10% OwnerPurchase6.5K$8.09$52.9K
Sep 15, 2022Opaleye Management Inc.10% OwnerPurchase5.2K$8.10$42.3K
Aug 19, 2022EW HEALTHCARE PARTNERS FUND 2, L.P.OtherPurchase500.0K$8.00$4.0M
Aug 16, 2022Opaleye Management Inc.10% OwnerPurchase315.0K$8.00$2.5M
Aug 12, 2022Opaleye Management Inc.10% OwnerPurchase5.0K$7.96$39.6K
Aug 12, 2022Opaleye Management Inc.10% OwnerPurchase12.0K$8.52$102.1K
Aug 3, 2022Opaleye Management Inc.10% OwnerPurchase5.0K$7.96$39.6K
Jul 22, 2022Opaleye Management Inc.10% OwnerPurchase5.2K$8.02$41.7K
Jul 21, 2022Opaleye Management Inc.10% OwnerPurchase10.3K$8.03$83.0K
Jul 20, 2022Opaleye Management Inc.10% OwnerPurchase5.1K$8.08$41.2K

Showing the 25 most recent of 102 Form 4 filings for TELA Bio, Inc..

Most active TELA insiders

  • EW HEALTHCARE PARTNERS FUND 2, L.P.65 filings
  • Opaleye Management Inc.18 filings
  • Roberto Cuca5 filings
  • ORBIMED ADVISORS LLC3 filings
  • Antony Koblish2 filings

Ask anything about TELA insider activity

Use Trabud's AI agent to query TELA Bio, Inc.'s Form 4 history in plain English — "Show me TELA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

TELA insider trading FAQ

Are TELA Bio, Inc. insiders buying or selling?

Across 102 SEC Form 4 filings, TELA Bio, Inc. (TELA) insiders reported 99 open-market purchases totaling $51.7M and 3 sales totaling $4.2M. That is a net buying position of $47.5M.

How many insiders trade TELA stock?

12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for TELA Bio, Inc.. The most recent filing was accepted on Nov 17, 2025.

Where does Trabud get TELA insider trading data?

All TELA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content